aap Implantate AG (HAM:AAQ1) ROCE % : -23.67% (As of Jun. 2023)

View and export this data going back to 1999. Start your Free Trial

What is aap Implantate AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. aap Implantate AG's annualized ROCE % for the quarter that ended in Jun. 2023 was -23.67%.

aap Implantate AG ROCE % Historical Data

The historical data trend for aap Implantate AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG ROCE % Chart

aap Implantate AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-18.38

-66.41

-46.43

-15.10

-20.69

aap Implantate AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial															-10.74	-19.68	-24.54	-16.15	-23.67

aap Implantate AG ROCE % Calculation

aap Implantate AG's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-3.241	/	( ( (22.954 - 6.337)	+	(20.228 - 5.52) )	/ 2 )
	=	-3.241	/	( (16.617	+	14.708)	/ 2 )
	=	-3.241	/	15.6625
	=	-20.69 %

aap Implantate AG's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-3.64	/	( ( (20.228 - 5.52)	+	(21.127 - 5.081) )	/ 2 )
	=	-3.64	/	( ( 14.708	+	16.046 )	/ 2 )
	=	-3.64	/	15.377
	=	-23.67 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

aap Implantate AG (HAM:AAQ1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

aap Implantate AG ROCE % Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

aap Implantate AG (HAM:AAQ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (HAM:AAQ1) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

AAQ1:Germany

Address

Lorenzweg 5, Berlin, DEU, 12099

Website

https://www.aap.de

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG (HAM:AAQ1) Headlines

No Headlines